Developing therapeutics against novel, tumor-selective targets and co-target pairs using bispecific antibodies

Series A proceeds fund advancement of the Company’s lead programs to clinical readiness and the identification of additional candidates

Dr. Raman, a seasoned industry veteran previously of Novartis and Flagship Pioneering, joins as CEO to advance InduPro pipeline

SEATTLE and CAMBRIDGE, Mass., June 13, 2024 — InduPro, Inc., a biotechnology company defining protein spatial relationships to create novel therapeutics for the treatment of cancer and autoimmune diseases, today announced an $85 million Series A financing co-led by The Column Group and Vida Ventures with participation from investors, including MRL Ventures Fund (the therapeutics-focused venture fund of Merck & Co, Inc.), Emerson Collective and Euclidean Capital. The financing will support the advancement of the first expected clinical product candidate targeting cancer tissue based on the proximity of co-targeted pairs, from preclinical development to an expected IND filing in Q4 2025 for a Phase 1 clinical trial. It will also fuel a pipeline of novel bispecific antibodies and antibody drug conjugates (ADCs) that utilizes protein proximity for identification of novel tumor selective target pairings.

Prakash Raman, Ph.D. joins as Chief Executive Officer of InduPro with more than two decades of biopharmaceutical business development and executive leadership experience, blending his scientific background, program and portfolio management and strong business development experience to lead and support biopharma companies.

InduPro therapeutically targets cell surface proteins in a variety of disease contexts by leveraging inherent or induced protein proximity. Through precise mapping of protein neighborhoods using its proprietary, high resolution proximity labeling technology, the Company is discovering novel co-target pairs that are highly selective for specific disease biology. Additionally, since protein proximity influences signals in cells that are critical for cellular health, proximity can be induced to modify cellular signaling and interactions in disease. InduPro’s approach relies on a unique discovery engine (ProXiMATE) to generate potential first-in-class and best-in-class novel therapeutic candidates across multiple indications and modalities.

“Our team is highly focused on precisely defining the spatial proximity of proteins on the surface of cells with high therapeutic potential across a broad range of indications and applications,” said Dr. Raman. “Instead of a limited subset of targets with known disease biology, we are discovering novel targets and best-in class approaches for areas of high unmet need for many cancer and autoimmune patients.”

The lead bispecific ADC program uses the Company’s Tumor Associated Proximity Antigen (TAPA) therapeutic approach to specifically target cancer tissue based on the proximity of co-targeted pairs discovered. In a separate ‘immunological synapse modulation’ approach, multi-specific antibodies are directed against targets whose induced proximity recruits and activates (or sequesters) proteins on the surface of immune cells in the treatment of autoimmune disease or immuno-oncology.

“Our approach provides unique insight into novel targets and mechanisms of biology by which to target and manipulate disease biology. This approach creates high patient impact and enables our first- and best-in class programs,” said Scott Lesley, Ph.D., President & Chief Scientific Officer. “Our ProXiMATE platform leverages deep learning analysis of protein microenvironment and membrane proteomic data to create an extensive knowledge base of highly-tuned protein proximity maps that continually generate novel and high-value tumor selective targets for ADCs and T cell engagers.”

“We are delighted that InduPro’s unique discovery engine is driven and supported by a talented team led by Prakash and will provide a strong foundation for a robust pipeline of potentially transformative therapeutics with opportunities for expansion and partnership,” said Sarah Hymowitz, Ph.D., partner at The Column Group and Board Chair of InduPro. “We look forward to collaborating with the InduPro team to bring novel and highly promising therapies to patients living with a wide range of cancers and autoimmune diseases.”

Dr. Raman previously served as President and CEO of Ribon Therapeutics, a biotech company focused on first-in-class small molecule drugs for Oncology and Immunology targeting the PARP family of enzymes. Prior to joining Ribon, Dr. Raman was a Senior Partner, Chief Business Development Officer at Flagship Pioneering, and held senior roles at Novartis for nearly 14 years, most recently as Vice President, Global Head of Novartis Institutes for Biomedical Research (NIBR) Business Development and Licensing. Dr. Raman completed his undergraduate work at the Indian Institute of Technology, Bombay, and received his Ph.D. in Organic and Medicinal Chemistry from the University of Wisconsin-Madison.

Formed in 2022 by Scientific Founder and recent Passano Award winner Chris Garcia, Ph.D., CSO Scott Lesley, Ph.D., and inventors of the protein proximity-based mapping technology, Rob Oslund Ph.D. and Niyi Fadeyi Ph.D., InduPro is led by a dedicated Board of Directors that includes Sarah Hymowitz, Ph.D., Board Chair from The Column Group, Helen Kim and Rajul Jain, M.D. from Vida Ventures, Peter Dudek, Ph.D. from MRL Ventures Fund, Rahul Ballal, Ph.D. CEO from Mediar Therapeutics, Craig Parker CEO from Surrozen, and InduPro CEO Prakash Raman, Ph.D.

About InduPro
InduPro is a biotechnology company defining and harnessing inherent and induced proximity biology to unlock next-generation therapeutics in cancer and autoimmune diseases. The Company develops therapeutics against novel, tumor-selective targets and co-target pairs using bispecific antibodies including antibody drug conjugates (ADCs) and T cell engagers (TCEs), fueling a robust pipeline of first- and best-in-class programs. To learn more, visit https://www.induprotx.com.

About The Column Group
The Column Group is a leading venture capital firm based in San Francisco that seeks to partner with exceptional scientific founders, entrepreneurs, executives, and investment organizations with a shared vision for building the next generation of drug discovery and development companies. TCG invests in disease-focused drug discovery companies with the potential to become leaders in their respective fields. These companies are strongly supported by the unique and complementary skill sets of TCG’s team, which includes prominent authorities in the scientific, operational, and financial arenas.

About Vida Ventures
Vida Ventures is a next-generation life sciences investment firm founded by scientists, physicians, entrepreneurs and investors passionate about building and funding breakthroughs in biomedicine. Together they form an independent, bold investment group bound together by a simple word – life. Its mission is to bring science to life and advance transformative biomedical innovations that have the potential to make a meaningful difference for patients. Vida has a bicoastal presence and currently has approximately $1.8 billion under management.

About MRL Ventures Fund
MRL Ventures Fund (MRLV) is the therapeutics-focused corporate venture fund of Merck & Co., Inc., with headquarters in Rahway, N.J., USA. From its headquarters in Cambridge, Mass., USA, the MRLV team invests globally in early-stage innovative therapeutics companies that are developing transformative medicines in any therapeutic area using any modality. The MRLV team of experienced life-sciences venture capital professionals is committed to supporting great entrepreneurs in their quest to create value through building companies that have a meaningful impact on health and disease. For more information, please visit: www.mrlv.com.

SOURCE InduPro

NEW YORK, June 13, 2024 — GPTZERO, the leading platform for AI-generated content detection and responsible AI adoption, today announced it has raised $10 million in Series A funding led by Footwork VC with participation from Reach Capital, Uncork, Neo, Alt Capital, and the former CEOs of Reuters and the NYT.

“As we spent time with the GPTZero team, we became more and more excited by what we learned,” says Nikhil Basu Trivedi at Footwork. “Their north star, in building an independent layer to measure and preserve authentic content on the internet, will only grow in importance in the years to come.”

This funding will enable GPTZero to redefine the interaction between humans and AI, enabling individuals, not AI companies, to measure and define the application of artificial intelligence on their own terms.

GPTZero’s roadmap includes launching and developing:  

• Hallucination detection: A core technology for ensuring the integrity of AI-generated content
• AI Sources: Identify the training data behind LLM outputs to judge how trustworthy they are and avoid reproducing copyrighted text
• GPTZero Docs: A new editor platform with an embedded AI that records and cites its AI usage. It includes education-specific functionality around limiting and watermarking AI outputs.

“We have been extremely fortunate to support a community of millions in identifying AI,” says CEO Edward Tian, “now we are committed to empowering teachers, students, writers, readers, and organizations to transparently interact with AI.”

SOURCE GPTZero

Abishek Kulshreshtha brings a wealth of knowledge and experience to the position

COLUMBIA, Md., June 13, 2024 — The Maryland Innovation Initiative (MII) Board of Directors announces the appointment of Abishek Kulshreshtha as the executive director of TEDCO’s MII program. In this position, Kulshreshtha will oversee all MII activities starting July 1, 2024.

As an independent unit within TEDCO, the Maryland Technology Development Corporation, MII was created to promote the commercialization of research conducted in five of Maryland’s academic research institutions (Johns Hopkins University; Morgan State University; University of Maryland, Baltimore; University of Maryland, Baltimore County; and University of Maryland, College Park) while leveraging each institution’s strengths. This collaborative program has supported more than 170 startup companies, created 370 jobs and procured more than $737 million in follow-on funding since its inception nearly 12 years ago. 

Recently, the program expanded to include opportunities at two comprehensive universities – Frostburg State University and Bowie State University. The addition of these pilot programs expands MII’s reach and allows for even more research to be brought to market.

“On behalf of the MII board of directors and our staff, we are thrilled to have Abi join our team. His experiences and perspectives, merging science and economic development, are perfect for the MII program,” said Renée Winsky, MII board chair. “I want to express my gratitude to my fellow board members and to our amazing MII team for their patience and support during this search process.”

Kulshreshtha’s experience positions him to be an asset for not only the MII program, but for the various site miners, researchers and innovators in the ecosystem that the program supports. His expertise includes economic development through innovation, translational research and commercialization. Most recently Kulshreshtha served as the chief business officer for Southern Research, where he oversaw business development, commercialization and economic development functions, launched a biotechnology accelerator, managed an intellectual property portfolio of nearly 200 patents and more. He holds a D.Phil. in theoretical physics from Oxford University and a bachelor’s degree in mathematical physics from Brown University.

“I am excited to begin this new journey with the MII team, the MII board and all of TEDCO,” said Kulshreshtha. “Their impact on Maryland’s economic development has been inspiring and I’m honored to be a part of the continued journey. Together, I know we can enhance MII’s impact, support more entrepreneurs, researchers and innovators in the ecosystem and bring more research to market.”

About TEDCO
TEDCO, the Maryland Technology Development Corporation, enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland. Learn more at www.tedcomd.com.

Media Contact
Tammi Thomas, Chief Development & Marketing Officer, TEDCO, [email protected]

SOURCE TEDCO

WASHINGTON, June 13, 2024 — Women Business Collaborative (WBC) announces an open call for applications for women entrepreneurs and capital investors to attend the Women’s Capital Summit, set for September 4-5, 2024, in New York, NY.

The Women’s Capital Summit is a dedicated platform for women entrepreneurs to access essential funding and for investors to discover high-potential women-owned businesses. With women-owned businesses making up 40% of all U.S. businesses and employing approximately 5.8 million people, the Summit underscores the critical need for financial backing to elevate these enterprises further.

“Women entrepreneurs bring invaluable innovation and leadership to the economy, yet often face hurdles in securing the capital needed for growth,” said Gwen K. Young, CEO of WBC. “We’re inviting women business owners and forward-thinking investors to join us at the Women’s Capital Summit and foster partnerships that will drive significant economic and social impact.”

The Summit will include:

• Investor Matchmaking: Sessions to connect women entrepreneurs with investors.
• Keynote Addresses: Hear from influential leaders and women entrepreneurs who have navigated the challenges of securing investment.
• Expert Panels: Discussions on current trends in entrepreneurship and investment, the future of women-led businesses, and strategies for overcoming funding obstacles.
• Networking Sessions: Opportunities for informal networking, enabling attendees to forge valuable connections with peers, mentors, and industry leaders.

Women Entrepreneurs

• Eligibility: Open to women entrepreneurs from all industries seeking investment to grow their businesses.
• How to Apply: Submit an application by June 30 at: https://wbcollaborative.org/wbc-events/womens-capital-summit/
• Benefits: Selected entrepreneurs will receive exclusive access to meet with investors and feature their company at the event.

Capital Investors

• Eligibility: Open to individual investors, venture capital firms, and funding organizations interested in supporting women entrepreneurs.
• How to Apply: Register at www.womenbusinesscollaborative.org/capitalwomenssummit
• Benefits: Investors can pre-schedule meetings with promising women entrepreneurs, access all summit sessions, and network with peers.

For more information, please email [email protected] or visit www.womenbusinesscollaborative.org/capitalwomenssummit.

About Women Business Collaborative (WBC)
Women Business Collaborative (WBC) is an unprecedented alliance of over 80 women’s business organizations and hundreds of business leaders building a movement to achieve equal position, pay, and power for all women in business. Through collaboration, advocacy, action, and accountability, we galvanize thousands of diverse professional women and men, business organizations, public and private companies to accelerate change. For more information on the Women Business Collaborative visit wbcollaborative.org.

SOURCE Women Business Collaborative

Backed by leading AI investors Daniel Gross and Nat Friedman, JACE can complete cognitively-complex, multi-step tasks by performing browser-based actions

SAN FRANCISCO, June 13, 2024 — Zeta Labs, an AI research and product company developing autonomous agents capable of efficiently performing complex and multi-step tasks, today announced the raise of its $2.9 million pre-seed round and the debut of its large language model (LLM)-based proprietary autonomous AI agent, JACE. The round was led by Daniel Gross, former head of AI at Y Combinator, and Nat Friedman, former Github CEO, with participation from Earlybird VC and Kaya VC as well as AI Grant, Shawn (swyx) Wang, Bartek Pucek and Mati Staniszewski, founder of ElevenLabs. Zeta Labs will use the funding to expand its engineering team, host training models, and enhance JACE’s overall infrastructure, improving its speed and reliability. 

A groundbreaking digital assistant, JACE represents the future of AI agents, going beyond traditional uses of current AI chatbots like ChatGPT and their text-generation focus. Instead, JACE focuses on taking action in the digital world. It differs from existing AI-powered chatbots due to its complex cognitive architecture, which enables it to complete high-difficulty tasks. Created by Zeta Labs, JACE can control and perform actions in the browser similarly to a human user, excelling in managing complex tasks that involve web automation, interaction and direct communication. This is due to the development and training of Zeta Labs’ proprietary web-interaction model, AWA-1 (Autonomous Web Agent-1), which enables JACE to reliably execute tasks over long periods of time, effectively handling the challenges and inconsistencies commonly found in web interfaces.

“At Zeta Labs, we aim to enable AI models to interact with the digital world around them. The development of our AWA-1 model allows JACE the ability to control a browser, essentially giving the AI assistant the digital equivalent of arms and legs,” said Peter Albert, co-founder of Zeta Labs. “You can’t ask any current chatbot on the market to book a trip, pay an invoice or set up a job post. With JACE, you can.”

By learning through extensive simulated interactions and utilizing synthetic data for rapid self-improvement, JACE developed the ability to navigate and utilize digital tools effectively. It is able to provide tangible assistance in a wide array of tasks from simple to-dos like making a restaurant reservation to more complex projects like setting up a recruitment pipeline or starting a business. The end result is a modern AI agent capable of assisting in a broad spectrum of tasks previously beyond the scope of chat-optimized AI models. By teaching JACE to control a browser, Zeta Labs created a system capable of emulating a substantial portion of day-to-day office work. To prove JACE’s efficacy and ability to go beyond the traditional AI-assistant role, the Zeta Labs team tested the autonomous agent by asking it to create a company on its own. Starting with a simple prompt, JACE led the user through creating a business plan, registered the business – a math tutoring company – found the first client and made its first revenue, all within two weeks. In the latest internal benchmark test conducted by Zeta Labs, which focused on the most common web-based tasks, like navigating the ordering process for a pizza delivery or finding two flats in London that meet specific criteria from the past week’s listings, JACE showed impressive performance. JACE performed the best when using Zeta Labs’ AWA-1 model, delivering an 89% task completion success rate, compared to when it used GPT-4o (68% success rate) and an open-source web agent using GPT-4o (25% success rate).

“In its current form, I see JACE as a meta-aggregator for web interfaces. Why learn to navigate all the different user interfaces when you can have a universal UI for everything?” said Fryderyk Wiatrowski, co-founder of Zeta Labs. “With JACE, you simply say what you need, and if you forget, it will ask you all the necessary questions up front. Imagine a universal service desk with a consultant who knows you personally and never needs to sleep. JACE will be that for you, just sitting there, ready to serve you at all times.”

Zeta Labs was co-founded by Fryderyk Wiatrowski and Peter Albert in August 2023. Albert, who launched his first e-commerce business eight years ago, noticed the extensive amount of office time spent on repetitive mundane tasks as he looked to fill operational roles. He wanted to create an environment where his team could focus on the interesting work that really mattered, while simultaneously being more efficient and effective. This vision laid the foundation for Zeta Labs and, after connecting with Wiatrowski during their time at Meta, where Albert was part of the core team behind Llama 2, the two decided to join forces.

“Web browsing was invented 34 years ago and forever changed the global economy, yet AI models don’t understand how to use it,” said Daniel Gross, Zeta Labs investor and entrepreneur known for founding Cue and Pioneer. “The next paradigm shift in AI is unlocking that behavior, and Zeta Labs is poised to make that happen. I am pleased to be an investor in this grand mission!”

To learn more about Zeta Labs and sign up for JACE’s waitlist, visit https://www.zetalabs.ai/.

About Zeta Labs 
Founded in 2024 by Fryderyk Wiatrowski and Peter Albert, Zeta Labs is an AI research and product lab dedicated to the art of possibility and the pursuit of significance. Their mission is to develop technologies that clear the path for humanity to engage with what truly matters. They are the creators of JACE, a proprietary AI agent based on large language models (LLMs) that is able to control and perform actions in the browser, like a human user would, and excels in managing interactive and complex tasks that require web interaction, automation, and direct communication functionalities. Engineered to navigate and utilize digital tools, JACE offers tangible assistance in a wide array of tasks, from routine activities like making a restaurant reservation to complex projects such as managing recruitment pipelines or launching businesses. JACE’s capability to complete cognitively-complex, multi-step tasks represents a significant advancement in AI capabilities. In 2024, the Zeta Labs team utilized this autonomous AI agent to establish the world’s first AI-created company.

SOURCE Zeta Labs

Startup that simplifies access to guided fishing, hunting experiences will enhance platform, expand to additional markets with latest funding.

MEMPHIS, Tenn., June 13, 2024 — AnyCreek, a Memphis-based startup simplifying access to guided experiences, such as fishing and hunting, with top guides and outfitters, announces the successful completion of a $1.8 million seed funding round. This round brings AnyCreek’s total funding since its launch in 2022 to $3.3 million with continued participation from Starting Line and other notable angel investors, and new participation from Bridge Investments, LaunchTN and others.

Since launching, AnyCreek developed a guide-centric platform that has helped thousands of adventurers across 183 markets easily discover, book, and pay for fishing and hunting experiences with the top guides and outfitters in the industry, while also fostering a community of outdoor enthusiasts.

According to the Bureau of Economic Analysis, the outdoor recreation economy accounted for 2.2 percent ($563.7 billion) of current‐dollar gross domestic product (GDP) for the nation in 2022, and Americans alone spent $144.8 billion on fishing and hunting in 2022, according to the U.S. Fish and Wildlife Survey with trip-related expenses making up $48.9 billion (34 percent).

With this latest round of funding, AnyCreek will continue enhancing its technology and expand into additional markets. Led by an accomplished growth leader at venture-backed companies like Compass, Groupon, and Zenefits, AnyCreek co-founder and CEO Benjamin Lazarov has a track record of driving business from tens of millions to billions in revenue, but his passion for the outdoor industry is what differentiates AnyCreek.

“We believe that humans in nature represent the best of human nature, and we have a profound respect for the businesses facilitating this connection,” said Benjamin Lazarov, co-founder and CEO of AnyCreek. “It’s our mission to equip guides and outfitters with the latest technology to get more people outside. This funding will help us continue this momentum as we expand into additional markets and offerings.”

AnyCreek transcends the traditional marketplace model by offering a comprehensive suite of vertical SaaS tools tailored for guides and outfitters, including calendar management, payments, referrals and easy guide assignments, SEO, marketing, customer communication, CRM, and 24/7 support.

“AnyCreek understands how I like to run my guide businesses and has built a technology that helps me grow and save a ton of time,” states Capt. Scott Owens of Southeastern Angling in Saint Simons Island, GA. “From managing deposits to streamlining customer communication, the platform has given me back a ton of time that I now enjoy spending with my family versus the hours on the phone responding to inquiries after a long day on the water.”

Not only does AnyCreek’s platform cater to the evolving needs of guides and outfitters, but also to adventurers in the digital era, by powering a modern booking experience for novice and experienced adventurers alike.

“With so many guides and outfitters offline, it can be challenging and intimidating to find great, local guides,” shared Nick Larson, co-founder and chief technology officer at AnyCreek. “Our platform is stress-tested by the best guides and outfitters and makes discovering, booking, and paying for high-quality hunting and fishing trips easy and convenient for any adventurer.”

AnyCreek’s seasoned leadership team––with experience from companies like Compass, Dropbox, and Costa––combines a proven track record of success and an unwavering commitment to the outdoor industry to capture significant market share.

“In today’s digitally-inclined landscape, AnyCreek strategically positions itself to capitalize on and cultivate consumers’ appetite for high-quality outdoor experiences, a growing industry where significant spending still occurs offline,” remarked Scott Holloway, general partner at Starting Line. “We take pride in supporting innovation that is shaping the future of the outdoor recreation sector.”

To learn more about AnyCreek, visit anycreek.com.

About AnyCreek
AnyCreek is the trusted way to get outside with the best guides on the planet. The industry’s top guides and outfitters rely on AnyCreek’s platform to manage their business, save time, and grow — making it easy for adventurers to discover and book once-in-a-lifetime trips. From hunting to fishing, anyone can find adventure outdoors at AnyCreek. Learn more at anycreek.com.

Media Contact: 
Leor Reef
[email protected]

SOURCE AnyCreek

NEW YORK, June 13, 2024 — J.P. Morgan Private Capital, a venture capital and growth equity investment team within J.P. Morgan Asset Management, today announced the final close of the first Life Sciences Private Capital offering, 270 Life Sciences Private Capital Fund I (the “Fund”), led by Chief Investment Officer Stephen Squinto, Ph.D. and Managing Partner Gaurav Gupta, M.D., M.S.E. The fund closed above its $500 million target, attracting strong support from investors, including institutional allocators, strategic corporate partners, family offices and high net worth individuals across North America, Europe, the Middle East, and Asia, as well as JPMorgan Chase & Co.

“We are pleased to announce the close of our inaugural fund, which was raised in just over a year, almost two times faster than our peers in the past decade¹,” said Dr. Stephen Squinto, Chief Investment Officer and Managing Partner of J.P. Morgan Life Sciences Private Capital. “As investors and company builders, we are strongly positioned at J.P. Morgan Private Capital to identify and support highly innovative companies that can shape the future of how patients are treated. Our mission is not only to capitalize companies, but also to utilize our collective experience to guide them towards successful outcomes, and to mentor a new generation of biotechnology founders and executives.”

The Fund invests in private biotechnology companies across stage, modality, therapeutic area, and geography. The Fund’s early company formation activities and portfolio investments span cardiometabolic disease, oncology, immunology, and genetic medicines. The Fund also aims to leverage the scale and resources of J.P. Morgan to add value to portfolio companies.

“We are grateful for the support of our investors, and for the key contributions of our strategic advisors and internal team members, as we announce the close of our inaugural life sciences venture capital fund. As the biotechnology industry enters the next era of scientific discovery, we strive to become a partner of choice for world-class researchers and entrepreneurs,” said Gaurav Gupta, M.D., M.S.E., Managing Partner of J.P. Morgan Life Sciences Private Capital.

About J.P. Morgan Private Capital

J.P. Morgan Private Capital provides customized financing solutions for private companies across the capital structure with a focus on venture and growth investing. The platform’s solutions span the consumer, technology, and life sciences sectors. J.P. Morgan Private Capital has a technology and consumer fund; J.P. Morgan Growth Equity Partners, with US$1 billion in aggregate commitments that closed in April 2023. Additionally a biotechnology venture fund; 270 Life Sciences Private Capital Fund I, with over US$500 million in aggregate commitments that closed in June 2024.

J.P. Morgan Private Capital is part of J.P. Morgan Global Alternatives, the alternative investment arm of J.P. Morgan Asset Management. With over 60 years of experience in managing alternative investments, $214 billion in assets under management and over 800 professionals (as of March 31, 2024), its strategies cover the full spectrum of alternatives: real estate, private equity, private credit, liquid alternative products, infrastructure, transport, hedge funds and forestry. From the Americas, Europe and Asia, independent alternative investment teams combine their cutting-edge expertise with J.P. Morgan’s resources, infrastructure and global reach to achieve each client’s specific objectives. For more information: jpmorgan.com/am  

About J.P. Morgan Asset Management

J.P. Morgan Asset Management, with assets under management of $3.1 trillion (as of December 31, 2023), is a global leader in investment management. J.P. Morgan Asset Management’s clients include institutions, retail investors and high net worth individuals in every major market throughout the world. J.P. Morgan Asset Management offers global investment management in equities, fixed income, real estate, hedge funds, private equity and liquidity. For more information: www.jpmorganassetmanagement.com. J.P. Morgan Asset Management is the marketing name for the asset management businesses of JPMorgan Chase & Co., and its affiliates worldwide.

JPMorgan Chase & Co. (the “Firm”) (NYSE: JPM) is a leading financial services firm based in the United States of America (“U.S.”), with operations worldwide. JPMorgan Chase had $3.9 trillion in assets and $328 billion in stockholders’ equity as of December 31, 2023. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management. Under the J.P. Morgan and Chase brands, the Firm serves millions of customers in the U.S., and many of the world’s most prominent corporate, institutional and government clients globally. Information about JPMorgan Chase & Co. is available at www.jpmorganchase.com.

¹ Preqin, 2024. Inclusive of first-time healthcare venture capital funds launched between 2014 and 2024.

SOURCE J.P. Morgan Asset Management

Funding to accelerate growth and fuel ongoing enhancements to the YourSixOS unified platform

ST. PAUL, Minn., June 13, 2024 — YourSix Inc., a leader in cloud physical security solutions, announced today that it has raised $10.5 million in Series A funding, led by Vocap Partners and joined by Eastside Partners. This investment is poised to accelerate growth, broaden market presence, and further its vision of transforming the delivery of commercial physical security solutions.

“We are extremely proud to have secured this substantial investment,” said Eric Styles, CEO of YourSix Inc. “In Vocap, we’ve found more than just a financial investor; they bring invaluable strategic support that aligns perfectly with our vision. With their partnership, we can build on our trusted role in guiding partners and customers in their transition from on-premise to cloud solutions, ensuring our mutual success.”

“YourSix’s team of industry experts and technologists deliver a modern, cloud-native physical security solution that uniquely meets the demands of a rapidly emerging ‘as-a-service’ market,” said Emery Waddell, Principal at Vocap Partners. “Their innovation is evident in their low latency, low bandwidth device-to-cloud methodology, scalability, and ease of use, as well as their channel-first go-to-market, all of which have established them as a trusted partner in the industry’s transition to modern cloud solutions. We look forward to working with Eric and his industry-leading team to help YourSix achieve its full potential.”

YourSix will use the funds from this round to support broader market penetration and accelerate the industry leading YourSixOS platform. With this investment, YourSix is well-positioned to continue its rapid growth and solidify its standing as a trusted security partner.

About YourSix Inc.
YourSix is an award-winning Physical Security as a Service (PSaaS) provider. The YourSixOS direct-to-cloud, unified platform leverages a unique convergence of surveillance, access control, audio, sensors, artificial intelligence, and monitoring to deliver a modern, cloud-native physical security solution. To learn more, visit www.yoursix.com.

About Vocap Partners
Vocap Partners provides capital, connections, and operational know-how to emerging B2B software and healthcare IT companies with disruptive potential. With offices in Atlanta, Georgia, and Vero Beach, Florida, Vocap has a strong track record of building and realizing value alongside entrepreneurs. To learn more, visit www.vocappartners.com.

About Eastside Partners
Eastside Partners is a growth equity firm that backs management teams who are building exceptional products and services. Since 2005, the firm has invested more than $250 million, focusing on B2B SaaS, Healthcare, and Tech-Enabled Services companies. Eastside’s investment strategy is focused on companies whose culture always puts the customer first. To learn more, visit www.eastsidepartners.com.

SOURCE YourSix Inc.

LOS ANGELES, June 13, 2024 — LawPro.ai, an innovative tech company that uses AI-driven solutions for the legal industry, announced today the successful completion of a seed investment round. This investment will accelerate LawPro.ai’s mission to transform the legal industry by leveraging cutting-edge AI technology to enhance efficiency, accuracy, and accessibility in law firms’ ability to review medical records.

The seed round was led by prominent venture capital firms, including The Legal Tech Fund and Scopus Ventures, with participation from notable angel investors with backgrounds in law and technology.

Modernizing Legal Services

With a strong customer base, LawPro’s technology is modernizing law firms’ ability to streamline their case intake and increase employee efficiency. “LawPro is a game changer for my team and me. Instead of taking hours to review, summarize, and understand medical records, now it gets done in minutes. This allows us to maximize our client’s case value in the shortest amount of time!” says Juan Carlos Puga, attorney at Saiontz & Kirk.

LawPro’s Co-Founder and CEO, Jeremy Schmerling says the industry has been asking for transformative technologies, “LawPro.ai is poised to redefine the legal landscape by streamlining legal workflows, enhancing decision-making, and improving client outcomes.”

Founders with a Vision

LawPro.ai was founded and backed by a group of industry veterans with decades of experience in the legal industry, SaaS enterprise software, and artificial intelligence. The founders bring a unique blend of expertise to the company including a senior partner at a leading law firm with extensive experience in complex litigation. Their leadership has successfully built companies and created new market verticals in the legal and software industries. LawPro.ai’s platform integrates advanced machine learning algorithms to automate routine legal tasks and offers intelligent insights that aid in case strategy and management.

Strategic Growth and Development

The new capital will be used to accelerate product development, expand the engineering and sales teams, and fuel go-to-market strategies. “This funding will enable us to scale our platform, expand our team, and continue developing transformative technologies that empower legal professionals and clients alike,” says Josh Schmerling, Co-Founder and Chief Strategy Officer of LawPro.

Investor Confidence

“We are excited to support LawPro.ai as they bring groundbreaking AI innovations to the legal industry,” said Bahram Nour-Omid, Managing Partner at Scopus Ventures. “Their platform addresses critical pain points in legal practice and has the potential to significantly enhance productivity and client satisfaction. We believe LawPro.ai is well-positioned to become a leader in legal technology.”

Zach Posner, Co-Founder and Managing Director at The Legal Tech Fund added, “We’re thrilled to be backing the team at LawPro. At The LegalTech Fund, we believe when lawyers are empowered with technology, they can better service their clients and expand their business. A key investment thesis for us is the use of software to unlock the source data of legal case documents, which is exactly what LawPro aims to do.”

About LawPro.ai

LawPro.ai is an AI-powered legal technology company dedicated to transforming the legal industry through innovative SaaS solutions. By combining deep legal expertise with state-of-the-art artificial intelligence, LawPro.ai empowers legal professionals to work more efficiently, make better-informed decisions, and deliver superior client outcomes. For more information, visit www.LawPro.ai. 

About The Legal Tech Fund

TLTF is a leading investment firm focused on supporting and scaling legal technology companies. With a deep understanding of the legal tech landscape, TLTF provides strategic investment and support to innovative companies driving change in the legal industry. For more information, visit www.legaltech.com.

About Scopus Ventures

Scopus Ventures is a venture capital firm dedicated to investing in early-stage technology companies with high growth potential. Scopus Ventures partners with visionary entrepreneurs to build companies that create significant value and impact. For more information, visit www.scopusventures.com.

About Saiontz & Kirk

Saiontz & Kirk, P.A. is a nationally known injury law firm that is focused exclusively on representing individuals. For more than 40 years, Saiontz & Kirk has helped clients with medical malpractice, automobile accidents, product liability and other personal injury lawsuits. For more information, visit www.youhavealawyer.com.

SOURCE LawPro.ai Inc.